Neurizon Therapeutics Ltd (ECQ0)

Currency in EUR
0.0900
0.0000(0.00%)
Delayed Data·
ECQ0 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ECQ0 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.09000.0900
52 wk Range
0.04200.1379
Key Statistics
Bid/Ask
0.09 / 0.099
Prev. Close
0.09
Open
0.09
Day's Range
0.09-0.09
52 wk Range
0.042-0.1379
Volume
-
Average Volume (3m)
5.62K
1-Year Change
6.51%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ECQ0 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Neurizon Therapeutics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Neurizon Therapeutics Ltd Company Profile

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.

Employees
4
Market
Germany

Compare ECQ0 to Peers and Sector

Metrics to compare
ECQ0
Peers
Sector
Relationship
P/E Ratio
−5.7x−6.6x−0.5x
PEG Ratio
0.09−0.020.00
Price/Book
7.0x1.7x2.6x
Price / LTM Sales
55.2x10.0x3.3x
Upside (Analyst Target)
-213.6%45.1%
Fair Value Upside
Unlock11.9%7.4%Unlock

Earnings

Latest Release
Feb 17, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
1.53M / --
EPS Revisions
Last 90 days

ECQ0 Income Statement

FAQ

What Stock Exchange Does Neurizon Therapeutics Ltd Trade On?

Neurizon Therapeutics Ltd is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Neurizon Therapeutics Ltd?

The stock symbol for Neurizon Therapeutics Ltd is "ECQ0."

What Is the Neurizon Therapeutics Ltd Market Cap?

As of today, Neurizon Therapeutics Ltd market cap is 44.12M.

What Is Neurizon Therapeutics Ltd's Earnings Per Share (TTM)?

The Neurizon Therapeutics Ltd EPS (TTM) is -0.03.

From a Technical Analysis Perspective, Is ECQ0 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Neurizon Therapeutics Ltd Stock Split?

Neurizon Therapeutics Ltd has split 1 times.

How Many Employees Does Neurizon Therapeutics Ltd Have?

Neurizon Therapeutics Ltd has 4 employees.

What is the current trading status of Neurizon Therapeutics Ltd (ECQ0)?

As of 04 Aug 2025, Neurizon Therapeutics Ltd (ECQ0) is trading at a price of 0.09, with a previous close of 0.09. The stock has fluctuated within a day range of 0.09 to 0.09, while its 52-week range spans from 0.04 to 0.14.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.